EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Comprehensive cardiac, vascular and pulmonary characterization of a cardiometabolic model of heart failure with preserved ejection fraction

Ibrahim Aykac, Christoph A. Baumgartner, Ouafa Hamza, Attila Kiss, Bruno K. Podesser

Disease Models & Mechanisms · 2026-11-01 · 19 (11)

DOI: 10.1242/dmm.053163 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome in which translational progress is limited by experimental models that insufficiently reflect the cardiometabolic phenotype while affecting endogenous endothelial function. We aimed to characterize a cardiometabolic ‘two-hit’ HFpEF model combining metabolic stress (db/db) with chronic mineralocorticoid excess (d-aldosterone). Female db/db mice received 4-week d-aldosterone (0.3 μg/h) or vehicle via osmotic minipumps. Metabolic profiling, high-resolution echocardiography including strain and left atrial mechanics, invasive right-heart catheterization and thoracic aortic wire myography were performed. Aldosterone-treated db/db mice developed cardiac hypertrophy and pulmonary congestion with preserved left ventricular ejection fraction but marked diastolic dysfunction, left atrial remodeling with increased stiffness and impaired global longitudinal left ventricular strain. Pulmonary hypertension with right ventricular dysfunction was evidenced by elevated right ventricular systolic pressure, reduced ratio of pulmonary acceleration time to pulmonary ejection time, and reduced tricuspid annular plane systolic excursion. Thoracic aortae from untreated db/db mice already showed impaired endothelium-dependent relaxation, which was further aggravated by aldosterone, whereas maximal endothelium-independent relaxation remained largely preserved. The db/db+d-aldosterone model recapitulates key features of cardiometabolic HFpEF across the cardiac-vascular-pulmonary axis and provides a translational platform for mechanistic and therapeutic studies targeting endothelial and ventricular-vascular dysfunction in HFpEF.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →